Kb Financial Partners, LLC Viatris Inc Transaction History

Kb Financial Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.02 - $10.29 $1,605 - $1,831	178 New	178 $2,000
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $1,365 - $1,791	161 New	161 $1,000
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $63,580 - $78,405	-6,390 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$9.81 - $15.4 $30,332 - $47,616	-3,092 Reduced 32.61%	6,390 $70,000
Q4 2021 Feb 18, 2022	BUY	$12.09 - $14.68 $114,637 - $139,195	9,482 New	9,482 $128,000
Q3 2021 Nov 16, 2021	SELL	$13.25 - $15.13 $113,380 - $129,467	-8,557 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$12.97 - $16.15 $34,474 - $42,926	-2,658 Reduced 23.7%	8,557 $122,000
Q1 2021 Jun 08, 2021	BUY	$13.59 - $18.54 $152,411 - $207,926	11,215 New	11,215 $157,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Kb Financial Partners, LLC with notifications on news.